非小细胞肺癌:新型靶向治疗为未来带来希望

Future Prescriber Pub Date : 2011-10-31 DOI:10.1002/fps.80

Marianne Nicolson MD, FRCP, Asa Dahle-Smith BSc, Mb ChB

{"title":"非小细胞肺癌:新型靶向治疗为未来带来希望","authors":"Marianne Nicolson MD, FRCP, Asa Dahle-Smith BSc, Mb ChB","doi":"10.1002/fps.80","DOIUrl":null,"url":null,"abstract":"Lung cancer remains a major healthcare challenge despite the recent reduction in incidence in the Western world and introduction of the public smoking ban in some countries. However, the complexity of tumour biology is being unravelled along with a greater understanding of molecular signalling pathways, opening up a new field of research into targeted therapies. Here the authors focus on non-small cell lung cancer (NSCLC), discussing its current management and some of the promising targeted therapies currently being investigated. Copyright © 2011 John Wiley & Sons, Ltd.","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"12 3","pages":"6-9"},"PeriodicalIF":0.0000,"publicationDate":"2011-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.80","citationCount":"0","resultStr":"{\"title\":\"NSCLC: novel targeted therapies offer hope for the future\",\"authors\":\"Marianne Nicolson MD, FRCP, Asa Dahle-Smith BSc, Mb ChB\",\"doi\":\"10.1002/fps.80\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Lung cancer remains a major healthcare challenge despite the recent reduction in incidence in the Western world and introduction of the public smoking ban in some countries. However, the complexity of tumour biology is being unravelled along with a greater understanding of molecular signalling pathways, opening up a new field of research into targeted therapies. Here the authors focus on non-small cell lung cancer (NSCLC), discussing its current management and some of the promising targeted therapies currently being investigated. Copyright © 2011 John Wiley & Sons, Ltd.\",\"PeriodicalId\":100566,\"journal\":{\"name\":\"Future Prescriber\",\"volume\":\"12 3\",\"pages\":\"6-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/fps.80\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future Prescriber\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/fps.80\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.80","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

NSCLC: novel targeted therapies offer hope for the future

Lung cancer remains a major healthcare challenge despite the recent reduction in incidence in the Western world and introduction of the public smoking ban in some countries. However, the complexity of tumour biology is being unravelled along with a greater understanding of molecular signalling pathways, opening up a new field of research into targeted therapies. Here the authors focus on non-small cell lung cancer (NSCLC), discussing its current management and some of the promising targeted therapies currently being investigated. Copyright © 2011 John Wiley & Sons, Ltd.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Future Prescriber

自引率

0.00%

发文量